greeksoup/ stock research
Stock research / United States / BNTX / Year to 31 December 2018

BioNTech SE (BNTX) annual results, year to 31 December 2018: revenue EUR 128 million, from the 20-F

BioNTech SE files a 20-F with the SEC once a year, in euros. In the year to 31 December 2018 it reported revenue of EUR 128 million ($151 million at the year's average rate), up 107.1% on the year before. Its profit attributable to shareholders was EUR -48.0 million.

Revenue
EUR 128 million
+107.1% on the year
FY2017FY2018
Operating margin
-42.2%
-99.5% a year earlier
FY2017FY2018
Net income
EUR -48.0 million
FY2017FY2018
Diluted EPS
n/a
FY2017FY2018

this yearthe year beforeIn euros as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2017Dec 2018
Revenue61.6128
Cost of sales9.313.7
Gross profit52.3114
Research and development85.5143
Operating profit-61.3-53.9
Finance costs26.00.0
Profit before tax-85.9-47.7
Income tax0.00.6
Profit for the year-86.0-48.3
Profit attributable to shareholders-85.7-48.0
Filing20-F20-F
EUR million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.

Cash flow

Year toDec 2017Dec 2018
Cash from operations-52.6-58.9
Purchase of property, plant and equipment24.329.9
Free cash flow-76.9-88.8
Cash from investing-52.5-66.5
Cash from financing-1.6365
Depreciation and amortisation10.522.0
Filing20-F20-F

EUR million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2017Dec 2018
Funded by
Equity attributable to shareholders-48.2266
Non-controlling interestsn/a0.8
Borrowings, as filedn/a0.0
Lease liabilitiesn/a50.8
Other liabilitiesn/a335
Total equity and liabilitiesn/a653
Owned
Property, plant and equipment49.666.2
Cash and cash equivalents172412
Inventoriesn/a5.8
Other assetsn/a169
Total assetsn/a653
Filing20-F20-F

EUR million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2017Dec 2018
Gross margin84.9%89.3%
Operating margin-99.5%-42.2%
Net margin-139.1%-37.6%
Free cash flow margin-124.8%-69.6%
Return on year-end equityn/a-18.0%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2018, filed 30 March 2021: the filing. The figures are in euros as filed.